Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Broadwin

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Biomedicines|March 28, 2024
Proteomic Profiling of SGLT-2 Inhibitor Canagliflozin in a Swine Model of Chronic Myocardial IschemiaDwight D Harris, Sharif A Sabe, Mark Broadwin, et al.
Bioengineering (Basel, Switzerland)|February 23, 2024
Intramyocardial Injection of Hypoxia-Conditioned Extracellular Vesicles Modulates Response to Oxidative Stress in the Chronically Ischemic MyocardiumDwight D Harris, Sharif A Sabe, Mark Broadwin, et al.
Physiological Reports|March 13, 2024
DPP-4 inhibitor sitagliptin treatment results in altered myocardial metabolic proteome and oxidative phosphorylation in a swine model of chronic myocardial ischemiaDwight D Harris, Sharif A Sabe, Mark Broadwin, et al.
Vessel Plus|November 20, 2023
Extracellular vesicle treatment partially reverts epigenetic alterations in chronically ischemic porcine myocardiumMark Broadwin, Ghazal Aghagoli, Sharif A Sabe, et al.
JTCVS Open|September 19, 2024
Intramyocardial injection of hypoxia-conditioned extracellular vesicles increases myocardial perfusion in a swine model of chronic coronary diseaseDwight D Harris, Sharif A Sabe, Mark Broadwin, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2025
Dipeptidyl peptidase-4 inhibitor linagliptin improves fibrosis, apoptosis, and cardiac function in a large animal model of chronic myocardial ischemiaDwight Douglas Harris, Christopher Stone, Mark Broadwin, et al.
Journal of the American College of Surgeons|January 30, 2024
Proteomic Analysis and Sex-Specific Changes in Chronically Ischemic Swine Myocardium Treated with Sodium-Glucose Cotransporter-2 Inhibitor CanagliflozinDwight D Harris, Sharif A Sabe, Mark Broadwin, et al.
Methods and Protocols|February 23, 2024
Crafting a Rigorous, Clinically Relevant Large Animal Model of Chronic Myocardial Ischemia: What Have We Learned in 20 Years?Christopher R Stone, Dwight D Harris, Mark Broadwin, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery DiseaseChristopher R Stone, Dwight D Harris, Mark Broadwin, et al.
JTCVS Open|October 9, 2023
Intramyocardial injection of hypoxia-conditioned extracellular vesicles modulates apoptotic signaling in chronically ischemic myocardiumDwight D Harris, Sharif A Sabe, Mohamed Sabra, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Biomedicines|March 28, 2024
Proteomic Profiling of SGLT-2 Inhibitor Canagliflozin in a Swine Model of Chronic Myocardial IschemiaDwight D Harris, Sharif A Sabe, Mark Broadwin, et al.
Bioengineering (Basel, Switzerland)|February 23, 2024
Intramyocardial Injection of Hypoxia-Conditioned Extracellular Vesicles Modulates Response to Oxidative Stress in the Chronically Ischemic MyocardiumDwight D Harris, Sharif A Sabe, Mark Broadwin, et al.
Physiological Reports|March 13, 2024
DPP-4 inhibitor sitagliptin treatment results in altered myocardial metabolic proteome and oxidative phosphorylation in a swine model of chronic myocardial ischemiaDwight D Harris, Sharif A Sabe, Mark Broadwin, et al.
Vessel Plus|November 20, 2023
Extracellular vesicle treatment partially reverts epigenetic alterations in chronically ischemic porcine myocardiumMark Broadwin, Ghazal Aghagoli, Sharif A Sabe, et al.
JTCVS Open|September 19, 2024
Intramyocardial injection of hypoxia-conditioned extracellular vesicles increases myocardial perfusion in a swine model of chronic coronary diseaseDwight D Harris, Sharif A Sabe, Mark Broadwin, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2025
Dipeptidyl peptidase-4 inhibitor linagliptin improves fibrosis, apoptosis, and cardiac function in a large animal model of chronic myocardial ischemiaDwight Douglas Harris, Christopher Stone, Mark Broadwin, et al.
Journal of the American College of Surgeons|January 30, 2024
Proteomic Analysis and Sex-Specific Changes in Chronically Ischemic Swine Myocardium Treated with Sodium-Glucose Cotransporter-2 Inhibitor CanagliflozinDwight D Harris, Sharif A Sabe, Mark Broadwin, et al.
Methods and Protocols|February 23, 2024
Crafting a Rigorous, Clinically Relevant Large Animal Model of Chronic Myocardial Ischemia: What Have We Learned in 20 Years?Christopher R Stone, Dwight D Harris, Mark Broadwin, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery DiseaseChristopher R Stone, Dwight D Harris, Mark Broadwin, et al.
JTCVS Open|October 9, 2023
Intramyocardial injection of hypoxia-conditioned extracellular vesicles modulates apoptotic signaling in chronically ischemic myocardiumDwight D Harris, Sharif A Sabe, Mohamed Sabra, et al.
Pageof 5